Advertisements



We are Sorry, This Page doesn't Exist


Gilead"s Kite Pharma Earns FDA Nod For Yescarta For Type Of Blood Cancer

read more.....»»

Category: blogSource: benzingaMar 8th, 2021

A gut-wrenching photo of a dead turtle stuck in fishing line puts the plastic problem in stark relief. The image won a prestigious award.

Shane Gross/Ocean Art A photo showing a dead Pacific green sea turtle caught in a piece of fishing line won an award in the Ocean Art Underwater Photo Competition. Abandoned fishing gear i.....»»

Category: topSource: businessinsiderJan 16th, 2020

Innate Pharma drops 9% after FDA puts Tellomak trial on hold

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 9th, 2020

Flags Waving As Holiday Approaches, With Tesla Quarter Showing Unexpected Strength

Wall Street parades into July 4 with stocks at record highs and with jobs data and earnings season straight ahead. At the same time, small-cap stocks are lagging a bit and Treasury yields continue to forecast some caution. read more.....»»

Category: blogSource: benzingaJul 3rd, 2019

Big Pharma Puts the Price Squeeze on Itself

Drugmakers are fighting for share in increasingly crowded markets of their own making......»»

Category: topSource: washpostApr 30th, 2019

California"s Kite Pharma plans to hire hundreds at new Frederick facility

Los Angeles biopharmaceutical company Kite Pharma plans to open a new manufacturing facility in Frederick County that will produce cell therapies for people with cancer. The company, a subsidiary of Gilead Sciences (NASDAQ: GILD), will build its.....»»

Category: topSource: bizjournalsApr 24th, 2019

U.S. puts 37 Chinese companies and schools on red-flag "unverified" list

The U.S. Commerce Department said on Wednesday that is adding 37 Chinese companies and schools to a red-flag list of "unverified" entities that U.S. companies should treat with caution, according to a notice in the Federal Register......»»

Category: topSource: reutersApr 11th, 2019

North Korea Puts Clocks Back 30 Minutes to Get in Sync With Seoul

Kim Jong Un said it was painful to see the clocks in the summit room last week showing different times for the two countries......»»

Category: topSource: newsweekApr 30th, 2018

Your Daily Pharma Scoop: Biohaven Updates, MEIP Offering, Kite European Expansions

Your Daily Pharma Scoop: Biohaven Updates, MEIP Offering, Kite European Expansions.....»»

Category: topSource: seekingalphaMay 17th, 2018

Small-Cap Biotechs Developing Novel Gene Therapies Could Become Targets of Big Pharma

The acquisition of Kite Pharmaceuticals by Gilead and Juno Therapeutics by Celgene may lead to more acquisitions of CAR-T gene therapy companiesRelated Stocks: GILD, NVS, CELG, MBIO, CYAD, CLLS, PFE, BLCM,.....»»

Category: worldSource: nytJun 20th, 2018

Small Caps, Technology and Pharma To Drive A Renewed Market Rally

We've been warning our followers not to become frightened by price rotation in the US majors for months. Our predictive analysis has been showing ........»»

Category: optionsSource: insidefuturesJun 22nd, 2018

Netflix Plunges More Than 4% Ahead of Earnings

Wall Street believes the streaming service could take over entertainment - but some investors are showing caution. Netflix stock dropped a dizzying 4.28% on Friday, wiping out the stock's.....»»

Category: europeSource: fortuneJul 14th, 2018

Marijuana News Today: Is Medical Marijuana the New Pharma Industry?

Marijuana News Today The marijuana news today puts the medical marijuana industry in a whole new light as the first ever U.S. Food and Drug Administration (FDA)-approved cannabis p.....»»

Category: analysisSource: profitconfidentialAug 15th, 2018

Teva Pharma puts active as shares attempt to recover losses

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 10th, 2018

This cancer-fighting biotech sped from startup to IPO filing in 10 months

The team that took Kite Pharma from a startup re-engineering a patient's own cells to fight cancer to a $12 billion buyout now is seeking a $100 million initial public offering for the South San Francisco company it launched only 10 months ago. Arie B.....»»

Category: topSource: bizjournalsSep 17th, 2018

More Caution Ahead in Top Semiconductor Companies

These were five of the top analyst calls showing caution in the semiconductor stocks from Tuesday, September 24, 2018......»»

Category: blogSource: 247wallstSep 25th, 2018

Pharma Remains The Key Debate For Johnson & Johnson, But Other Segments Showing Signs Of A Recovery

Pharma Remains The Key Debate For Johnson & Johnson, But Other Segments Showing Signs Of A Recovery.....»»

Category: topSource: seekingalphaNov 12th, 2018

Kite Pharma announces updated Zuma-3 data from KTE-X19 Phase 1/2 study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 3rd, 2018

Gilead’s Kite Failure Shows Dangers of Speculation Even at the Top Tier

Gilead bought CAR-T firm Kite Pharma for nearly $12 billion in 2017. Now, after an $820 million write-down on one Kite asset, some analysts say Gilead may have to write down the whole thingRelated Stocks: GILD, BLUE,.....»»

Category: blogSource: gurufocusFeb 6th, 2019

Bitcoin Up 3%: What Will Inflation Data And Powell Speech Bring This Week?

Bitcoin (CRYPTO: BTC) is carefully maintaining the $60,000 support level, navigating a delicate balance between bullish optimism and bearish caution. read more.....»»

Category: blogSource: benzinga14 hr. 2 min. ago